Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs-Reference-Cited by-同舟云学术

Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs

Published:2016-03-30 Issue:sup1 Volume:31 Page:177-183
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Jabłońska-Trypuć Agata¹,Matejczyk Marzena¹,Rosochacki Stanisław¹

Affiliation:

1. Department of Sanitary Biology and Biotechnology, Faculty of Civil Engineering and Environmental Engineering, Bialystok University of Technology, Białystok, Poland

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/14756366.2016.1161620

Reference48 articles.

1. The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis

2. The collagen superfamily: from the extracellular matrix to the cell membrane

3. The collagen family members as cell adhesion proteins

4. Collagens—structure, function, and biosynthesis

5. Collagens, modifying enzymes and their mutations in humans, flies and worms

Cited by 738 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virtual screening reveals fluorescent probes for detecting Pan-Zinc center activity in serum MMPs: A potential biomarker for early tumor screening;Chemical Engineering Journal;2024-10

2. New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma;Scientific Reports;2024-09-09

3. Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies;Journal of Hematology & Oncology;2024-09-04

4. Repeated Silica exposures lead to Silicosis severity via PINK1/PARKIN mediated mitochondrial dysfunction in mice model;Cellular Signalling;2024-09

5. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09